XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
[2]
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
[2]
Treasury Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
[2]
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interests
Beginning balance at Dec. 31, 2019 $ 1,232.4   $ 0.4 $ 762.8   $ 0.0 $ 500.3   $ (35.9) $ 4.8
Beginning balance (shares) at Dec. 31, 2019     35,800,000              
Increase (Decrease) in Stockholders' Equity                    
Net income 8.5           8.5      
Other comprehensive income (loss) (9.9)               (9.9)  
Share-based compensation expense 2.9     2.9            
Common stock issued from share-based compensation plans 2.0     2.0            
Common stock issued from share-based compensation plans (shares)     160,000              
Common stock repurchases [1] (19.3)         (19.3)        
Common stock repurchases from share-based compensation plans (1.7)     (1.7)            
Common stock repurchases from share-based compensation plans (in shares)     (10,000.00)              
Ending balance at Mar. 31, 2020 1,214.9   $ 0.4 766.0   (19.3) 508.8   (45.8) 4.8
Ending balance (shares) at Mar. 31, 2020     35,950,000              
Beginning balance at Dec. 31, 2019 1,232.4   $ 0.4 762.8   0.0 500.3   (35.9) 4.8
Beginning balance (shares) at Dec. 31, 2019     35,800,000              
Increase (Decrease) in Stockholders' Equity                    
Net income 29.5                  
Ending balance at Jun. 30, 2020 1,246.4   $ 0.4 768.6   (19.3) 528.9   (37.9) 5.7
Ending balance (shares) at Jun. 30, 2020     35,990,000              
Beginning balance at Mar. 31, 2020 1,214.9   $ 0.4 766.0   (19.3) 508.8   (45.8) 4.8
Beginning balance (shares) at Mar. 31, 2020     35,950,000              
Increase (Decrease) in Stockholders' Equity                    
Net income 21.0           20.1     0.9
Other comprehensive income (loss) 7.9               7.9  
Share-based compensation expense 2.0     2.0            
Common stock issued from share-based compensation plans 0.6     0.6            
Common stock issued from share-based compensation plans (shares)     40,000.00              
Ending balance at Jun. 30, 2020 1,246.4   $ 0.4 768.6   (19.3) 528.9   (37.9) 5.7
Ending balance (shares) at Jun. 30, 2020     35,990,000              
Beginning balance at Dec. 31, 2020 $ 1,579.3 $ (26.2) $ 0.4 780.8 $ (36.9) (19.3) 808.4 $ 10.7 2.4 6.6
Beginning balance (shares) at Dec. 31, 2020 36,185,829   36,190,000              
Increase (Decrease) in Stockholders' Equity                    
Net income $ 26.1           25.6     0.5
Other comprehensive income (loss) (19.2)               (19.2)  
Share-based compensation expense 3.4     3.4            
Common stock issued from share-based compensation plans 5.6     5.6            
Common stock issued from share-based compensation plans (shares)     180,000              
Common stock repurchases from share-based compensation plans (3.0)     (3.0)            
Common stock repurchases from share-based compensation plans (in shares)     (20,000.00)              
Other 0.0     0.1           (0.1)
Ending balance at Mar. 31, 2021 1,566.0   $ 0.4 750.0   (19.3) 844.7   (16.8) 7.0
Ending balance (shares) at Mar. 31, 2021     36,350,000              
Beginning balance at Dec. 31, 2020 $ 1,579.3 $ (26.2) $ 0.4 780.8 $ (36.9) (19.3) 808.4 $ 10.7 2.4 6.6
Beginning balance (shares) at Dec. 31, 2020 36,185,829   36,190,000              
Increase (Decrease) in Stockholders' Equity                    
Net income $ 32.9                  
Ending balance at Jun. 30, 2021 $ 1,583.8   $ 0.4 753.3   (19.3) 851.2   (9.2) 7.4
Ending balance (shares) at Jun. 30, 2021 36,375,301   36,380,000              
Beginning balance at Mar. 31, 2021 $ 1,566.0   $ 0.4 750.0   (19.3) 844.7   (16.8) 7.0
Beginning balance (shares) at Mar. 31, 2021     36,350,000              
Increase (Decrease) in Stockholders' Equity                    
Net income 6.8           6.5     0.3
Other comprehensive income (loss) 7.6               7.6  
Share-based compensation expense 2.4     2.4            
Common stock issued from share-based compensation plans 0.9     0.9            
Common stock issued from share-based compensation plans (shares)     30,000.00              
Other 0.1                 0.1
Ending balance at Jun. 30, 2021 $ 1,583.8   $ 0.4 $ 753.3   $ (19.3) $ 851.2   $ (9.2) $ 7.4
Ending balance (shares) at Jun. 30, 2021 36,375,301   36,380,000              
[1] Includes $19.3 in shares repurchased through our share repurchase program. On March 11, 2021, the share repurchase program expired with no further repurchases. Refer to Note 1, “Basis of Preparation” for further information.
[2] Refer to Note 1, “ Basis of Preparation” for discussion regarding the cumulative effect of change in accounting principle.